SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thomas Müller, Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease, Drugs, 2015, 75, 2, 157

    CrossRef

  2. 2
    Hyeyoung Park, Jee Young Lee, Cheol Min Shin, Jong-Min Kim, Tae Jeong Kim, Ji Won Kim, Characterization of gastrointestinal disorders in patients with parkinsonian syndromes, Parkinsonism & Related Disorders, 2015,

    CrossRef

  3. 3
    Kayode Ogungbenro, Henry Pertinez, Leon Aarons, Empirical and Semi-Mechanistic Modelling of Double-Peaked Pharmacokinetic Profile Phenomenon Due to Gastric Emptying, The AAPS Journal, 2015, 17, 1, 227

    CrossRef

  4. 4
    Eamonn M.M. Quigley, Other Forms of Gastroparesis, Gastroenterology Clinics of North America, 2015, 44, 1, 69

    CrossRef

  5. 5
    Dirk Woitalla, Jan Kassubek, Lars Timmermann, Thomas Lauterbach, Reinhard Berkels, Frank Grieger, Thomas Müller, Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial, Parkinsonism & Related Disorders, 2015, 21, 3, 199

    CrossRef

  6. 6
    James G. Greene, Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease, Antioxidants & Redox Signaling, 2014, 21, 4, 649

    CrossRef

  7. You have free access to this content7
    Sarah Marrinan, Anton V. Emmanuel, David J. Burn, Delayed gastric emptying in Parkinson's disease, Movement Disorders, 2014, 29, 1
  8. 8
    Anna Bencsik, Letizia Muselli, Mikael Leboidre, Latifa Lakhdar, Thierry Baron, Early and Persistent Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice, Journal of Neuropathology & Experimental Neurology, 2014, 73, 12, 1144

    CrossRef

  9. 9
    L.-F. Zheng, J. Song, R.-F. Fan, C.-L. Chen, Q.-Z. Ren, X.-L. Zhang, X.-Y. Feng, Y. Zhang, L.-S. Li, J.-X. Zhu, The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra, Acta Physiologica, 2014, 211, 2
  10. 10
    Jin Song, Lifei Zheng, Xiaoli Zhang, Xiaoyan Feng, Ruifang Fan, Lu Sun, Feng Hong, Yue Zhang, Jinxia Zhu, Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease, Translational Research, 2014, 164, 1, 22

    CrossRef

  11. 11
    Charles H. Knowles, Greger Lindberg, Emanuele Panza, Roberto De Giorgio, New perspectives in the diagnosis and management of enteric neuropathies, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 4, 206

    CrossRef

  12. 12
    Ali Reza Noorian, Jennifer Rha, Dana M. Annerino, Douglas Bernhard, Georgia M. Taylor, James G. Greene, Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system, Neurobiology of Disease, 2012, 48, 1, 9

    CrossRef

  13. 13
    Ronald F Pfeiffer, Autonomic dysfunction in Parkinson's disease, Expert Review of Neurotherapeutics, 2012, 12, 6, 697

    CrossRef

  14. 14
    Maria G. Cersosimo, Eduardo E. Benarroch, Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers, Journal of the Neurological Sciences, 2012, 313, 1-2, 57

    CrossRef

  15. 15
    K. Del Tredici, W.H. Jost, Gastrointestinale Störungen beim idiopathischen Parkinson-Syndrom, Der Nervenarzt, 2012, 83, 10, 1282

    CrossRef

  16. 16
    Zaid S. Heetun, Eamonn M.M. Quigley, Gastroparesis and Parkinson’s disease: A systematic review, Parkinsonism & Related Disorders, 2012, 18, 5, 433

    CrossRef

  17. 17
    L. Wang, I. Magen, P.-Q. Yuan, S. R. Subramaniam, F. Richter, M.-F. Chesselet, Y. Taché, Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation, Neurogastroenterology & Motility, 2012, 24, 9
  18. 18
    Dana M. Annerino, Shawn Arshad, Georgia M. Taylor, Charles H. Adler, Thomas G. Beach, James G. Greene, Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss, Acta Neuropathologica, 2012, 124, 5, 665

    CrossRef

  19. 19
    Thomas Müller, Manfred Gerlach, Moussa B.H. Youdim, Peter Riederer, Neurobiology of Psychiatric Disorders, 2012,

    CrossRef

  20. 20
    Thomas Chelimsky, David Robertson, Gisela Chelimsky, Neurology in Clinical Practice, 2012,

    CrossRef

  21. 21
    Ronald F. Pfeiffer, Gastrointestinal dysfunction in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 1, 10

    CrossRef

  22. 22
    Leslie J. Cloud, James G. Greene, Gastrointestinal Features of Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2011, 11, 4, 379

    CrossRef

  23. 23
    Yuji Tanaka, Tomohiro Kato, Hiroshi Nishida, Megumi Yamada, Akihiro Koumura, Takeo Sakurai, Yuichi Hayashi, Akio Kimura, Isao Hozumi, Hiroshi Araki, Masahiko Murase, Masahito Nagaki, Hisataka Moriwaki, Takashi Inuzuka, Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test, Journal of Neurology, 2011, 258, 3, 421

    CrossRef

  24. 24
    Eamonn M.M. Quigley, Seamus O'Mahony, Zaid Heetun, Motility Disorders in the Patient with Neurologic Disease, Gastroenterology Clinics of North America, 2011, 40, 4, 741

    CrossRef

  25. 25
    Marcus M. Unger, Jens C. Möller, Katharina Mankel, Katrin Schmittinger, Karla M. Eggert, Maria Stamelou, Karin Stiasny-Kolster, Katharina Bohne, Maren Bodden, Geert Mayer, Wolfgang H. Oertel, Johannes J. Tebbe, Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test, Movement Disorders, 2011, 26, 14
  26. 26
    Li-Fei Zheng, Zhi-Yong Wang, Xiao-feng Li, Jin Song, Feng Hong, Hui Lian, Qian Wang, Xiao-Yan Feng, Yuan-yuan Tang, Yue Zhang, Jin-Xia Zhu, Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease, Brain Research, 2011, 1420, 59

    CrossRef

  27. 27
    D. Woitalla, O. Goetze, Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives, Journal of the Neurological Sciences, 2011, 310, 1-2, 152

    CrossRef

  28. 28
    Christopher A. Lieu, Allen R. Kunselman, Bala V. Manyam, Kala Venkiteswaran, Thyagarajan Subramanian, A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias, Parkinsonism & Related Disorders, 2010, 16, 7, 458

    CrossRef

  29. 29
    Thomas Müller, Entacapone, Expert Opinion on Drug Metabolism & Toxicology, 2010, 6, 8, 983

    CrossRef

  30. 30
    Wolfgang H. Jost, Gastrointestinal dysfunction in Parkinson's Disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 69

    CrossRef

  31. 31
    Angelo Antonini, K. Ray Chaudhuri, Pablo Martinez-Martin, Per Odin, Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease, CNS Drugs, 2010, 24, 2, 119

    CrossRef

  32. 32
    Marcus M. Unger, Katja Hattemer, Jens C. Möller, Katrin Schmittinger, Katharina Mankel, Karla Eggert, Konstantin Strauch, Johannes J. Tebbe, Boris Keil, Wolfgang H. Oertel, Johannes T. Heverhagen, Susanne Knake, Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease, Movement Disorders, 2010, 25, 5
  33. 33
    James G. Greene, Ali Reza Noorian, Shanthi Srinivasan, Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease, Experimental Neurology, 2009, 218, 1, 154

    CrossRef

  34. 34
    Anna Krygowska-Wajs, William P. Cheshire, Zbigniew K. Wszolek, Alicja Hubalewska-Dydejczyk, Barbara Jasinska-Myga, Matthew J. Farrer, Marek Moskala, Anna Sowa-Staszczak, Evaluation of gastric emptying in familial and sporadic Parkinson disease, Parkinsonism & Related Disorders, 2009, 15, 9, 692

    CrossRef

  35. 35
    Michela Barichella, Emanuele Cereda, Gianni Pezzoli, Major nutritional issues in the management of Parkinson's disease, Movement Disorders, 2009, 24, 13
  36. 36
    Thomas Müller, Dirk Woitalla, Oliver Goetze, Christoph Erdmann, Entacapone improves absorption of a coadministered salt in patients with Parkinson's disease, Movement Disorders, 2008, 23, 10
  37. You have free access to this content37
    Neal Hermanowicz, Fatal gastroparesis in a patient with Parkinson's disease, Movement Disorders, 2008, 23, 1
  38. 38
    Dag Nyholm, Hans Lennernäs, Irregular gastrointestinal drug absorption in Parkinson's disease, Expert Opinion on Drug Metabolism & Toxicology, 2008, 4, 2, 193

    CrossRef

  39. 39
    William L. Hasler, Gastroparesis: Symptoms, Evaluation, and Treatment, Gastroenterology Clinics of North America, 2007, 36, 3, 619

    CrossRef

  40. 40
    Trevor Treasure, Jeffrey Bennett, Office-based Anesthesia, Oral and Maxillofacial Surgery Clinics of North America, 2007, 19, 1, 45

    CrossRef

  41. 41
    J. J. L. HAANS, A. A. M. MASCLEE, Review article: the diagnosis and management of gastroparesis, Alimentary Pharmacology & Therapeutics, 2007, 26,
  42. 42
    Anil S Modak, Stable isotope breath tests in clinical medicine: a review, Journal of Breath Research, 2007, 1, 1, 014003

    CrossRef

  43. 43
    Ronald F. Pfeiffer, Gastrointestinal and Swallowing Disturbances in Parkinson's Disease,